Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

Free Guide: Find the Next Crorepati Stock in this Futuristic Industry

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 507.05 0.13% 503.85 -0.40%
 More Info 
AJANTA PHARMA 980.25 0.32% 979.55 -0.03%
 More Info 
ALEMBIC PHARMA 551.15 0.01% 551.75 0.30%
 More Info 
BIOCON 292.55 -0.15% 292.35 -0.17%
 More Info 
CADILA HEALTHCARE 261.00 -1.08% 261.00 -1.14%
 More Info 
CIPLA 461.35 0.16% 461.25 0.04%
 More Info 
DIVIS LABORATORIES 1,839.95 0.55% 1,842.00 0.70%
 More Info 
DR. REDDYS LAB 2,822.85 -2.84% 2,821.50 -2.90%
 More Info 
GLENMARK PHARMA 339.70 -0.48% 339.60 -0.59%
 More Info 
INDOCO REMEDIES 148.50 1.75% 147.40 1.06%
 More Info 
IPCA LABS 1,133.35 0.82% 1,133.05 0.84%
 More Info 
J.B.CHEMICALS 419.65 1.23% 419.95 1.16%
 More Info 
LUPIN 756.25 1.03% 756.25 1.00%
 More Info 
NATCO PHARMA 582.50 0.86% 582.80 0.94%
 More Info 
NIFTY 50 Not Listed 12,086.70 0.96%
 More Info 
ORCHID PHARMA LTD 5.25 -4.89% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 113.70 2.11% 113.75 2.39%
 More Info 
PIRAMAL ENTERPRISES 1,677.15 1.20% 1,677.55 1.19%
 More Info 
S&P BSE SENSEX 41,009.71 1.05% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 368.55 0.30% 369.05 0.35%
 More Info 
SUN PHARMA 438.65 1.12% 439.25 1.17%
 More Info 
TORRENT PHARMA 1,865.90 0.41% 1,865.60 0.43%
 More Info 
WOCKHARDT 241.75 0.50% 242.00 0.58%
 More Info 

BSE prices: December 13, 2019  (Close)    NSE prices: December 13, 2019  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 8,030.1 (down 0.2%). The index is down 22.1% over the last 30 days. And over the last 1 year, it has lost 14.5%.

Within the Indian Pharma sector, the top gainers were PANACEA BIOTECH (up 2.1%) and INDOCO REMEDIES (up 1.8%). On the other hand, DR. REDDYS LAB (down 2.8%) and CADILA HEALTHCARE (down 1.1%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 12,086.7 (up 1.0%).




Today's Market

Rising Inflation and Onion Effect: Your Inside Scoop on the Markets(Podcast)

Stock markets remained rangebound this week too. Macroeconomic news globally and domestically remained the focus of the week.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CIPLA Announces Quarterly Results (2QFY20); Net Profit Up 31.2% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, CIPLA has posted a net profit of Rs 5 bn (up 31.2% YoY). Sales on the other hand came in at Rs 44 bn (up 9.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

How We Made 14.64% Trading Profit in Just 2 Days

Dec 12, 2019

A high probability trade that worked to perfection for my subscribers.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020 (Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks (Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets? (The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Dec 13, 2019 (Close)

COMPARE COMPANY

MARKET STATS